Myriad Genetics (MYGN) risk factors

Item 1A of every Myriad Genetics Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open MYGN in Gloom →

Myriad Genetics' chart, financials and news, free in your browser.Open MYGN in Gloom →

FY2025 10-K risk factors
50 risks5 new3 dropped16 reworded
Myriad Genetics added risks regarding trade tariffs, courier disruptions, EndoPredict discontinuance, and shareholder activism. The company also updated its credit facility covenants, AI usage scope, and strategic focus on the Cancer Care Continuum.
Filed Feb 24, 2026
FY2024 10-K risk factors
48 risks
Filed Feb 28, 2025